vs
ALTISOURCE PORTFOLIO SOLUTIONS S.A.（ASPS）与PUMA BIOTECHNOLOGY, INC.（PBYI）财务数据对比。点击上方公司名可切换其他公司
PUMA BIOTECHNOLOGY, INC.的季度营收约是ALTISOURCE PORTFOLIO SOLUTIONS S.A.的1.8倍（$75.5M vs $42.3M），PUMA BIOTECHNOLOGY, INC.同比增速更快（27.7% vs 3.2%），PUMA BIOTECHNOLOGY, INC.自由现金流更多（$14.4M vs $-525.0K），过去两年PUMA BIOTECHNOLOGY, INC.的营收复合增速更高（31.3% vs 3.6%）
Altisource Portfolio Solutions S.A.是面向抵押贷款、房地产及消费金融领域的全球服务商，为贷款机构、服务商、投资者等市场参与者提供技术、数据与运营解决方案，优化资产管理、房产交易等业务流程，提升客户运营效率。
彪马生物技术是一家公开上市的生物制药企业，总部位于美国加利福尼亚州洛杉矶，专注于创新药物研发相关业务，在生物制药领域开展研发与商业化运营。
ASPS vs PBYI — 直观对比
营收规模更大
PBYI
是对方的1.8倍
$42.3M
营收增速更快
PBYI
高出24.5%
3.2%
自由现金流更多
PBYI
多$14.9M
$-525.0K
两年增速更快
PBYI
近两年复合增速
3.6%
损益表 — Q4 FY2025 vs Q4 FY2025
| 指标 | | |
|---|---|---|
| 营收 | $42.3M | $75.5M |
| 净利润 | $-7.1M | — |
| 毛利率 | 26.5% | 69.3% |
| 营业利润率 | -15.5% | 22.7% |
| 净利率 | -16.8% | — |
| 营收同比 | 3.2% | 27.7% |
| 净利润同比 | 18.2% | — |
| 每股收益（稀释后） | $-1.02 | $0.26 |
绿色 = 该指标领先。财年不对齐时期间可能不同
8季度营收与利润趋势
并排季度历史对比，按日历期对齐，财年错位的公司也能正确匹配
营收ASPSPBYI
| Q4 25 | $42.3M | $75.5M | ||
| Q3 25 | $41.9M | $54.5M | ||
| Q2 25 | $43.3M | $52.4M | ||
| Q1 25 | $43.4M | $46.0M | ||
| Q4 24 | $41.0M | $59.1M | ||
| Q3 24 | $40.5M | $80.5M | ||
| Q2 24 | $39.1M | $47.1M | ||
| Q1 24 | $39.5M | $43.8M |
净利润ASPSPBYI
| Q4 25 | $-7.1M | — | ||
| Q3 25 | $-2.3M | $8.8M | ||
| Q2 25 | $16.7M | $5.9M | ||
| Q1 25 | $-5.3M | $3.0M | ||
| Q4 24 | $-8.7M | — | ||
| Q3 24 | $-9.3M | $20.3M | ||
| Q2 24 | $-8.3M | $-4.5M | ||
| Q1 24 | $-9.2M | $-4.8M |
毛利率ASPSPBYI
| Q4 25 | 26.5% | 69.3% | ||
| Q3 25 | 27.1% | 77.7% | ||
| Q2 25 | 30.1% | 76.5% | ||
| Q1 25 | 30.7% | 77.1% | ||
| Q4 24 | 30.3% | 76.4% | ||
| Q3 24 | 29.8% | 63.9% | ||
| Q2 24 | 32.5% | 77.4% | ||
| Q1 24 | 31.2% | 75.5% |
营业利润率ASPSPBYI
| Q4 25 | -15.5% | 22.7% | ||
| Q3 25 | 1.2% | 17.6% | ||
| Q2 25 | 7.5% | 12.7% | ||
| Q1 25 | 7.5% | 8.7% | ||
| Q4 24 | 1.4% | 22.6% | ||
| Q3 24 | 2.7% | 27.4% | ||
| Q2 24 | 5.3% | -4.6% | ||
| Q1 24 | -1.4% | -5.3% |
净利率ASPSPBYI
| Q4 25 | -16.8% | — | ||
| Q3 25 | -5.5% | 16.2% | ||
| Q2 25 | 38.5% | 11.2% | ||
| Q1 25 | -12.1% | 6.5% | ||
| Q4 24 | -21.3% | — | ||
| Q3 24 | -23.0% | 25.2% | ||
| Q2 24 | -21.1% | -9.6% | ||
| Q1 24 | -23.2% | -11.0% |
每股收益（稀释后）ASPSPBYI
| Q4 25 | $-1.02 | $0.26 | ||
| Q3 25 | $-0.22 | $0.17 | ||
| Q2 25 | $1.48 | $0.12 | ||
| Q1 25 | $-0.09 | $0.06 | ||
| Q4 24 | $-4.72 | $0.40 | ||
| Q3 24 | $-2.61 | $0.41 | ||
| Q2 24 | $-2.33 | $-0.09 | ||
| Q1 24 | $-0.33 | $-0.10 |
资产负债表与财务实力
最新季度各公司的流动性、杠杆与账面价值一览
| 指标 | | |
|---|---|---|
| 现金及短期投资手头流动性 | $26.6M | $97.5M |
| 总债务越低越好 | $191.1M | $22.7M |
| 股东权益账面价值 | $-110.2M | $130.3M |
| 总资产 | $139.8M | $216.3M |
| 负债/权益比越低杠杆越低 | — | 0.17× |
8季度趋势，按日历期对齐
现金及短期投资ASPSPBYI
| Q4 25 | $26.6M | $97.5M | ||
| Q3 25 | $28.6M | $94.4M | ||
| Q2 25 | $30.0M | $96.0M | ||
| Q1 25 | $30.8M | $93.2M | ||
| Q4 24 | $29.8M | $101.0M | ||
| Q3 24 | $28.3M | $96.7M | ||
| Q2 24 | $29.7M | $96.8M | ||
| Q1 24 | $29.6M | $107.2M |
总债务ASPSPBYI
| Q4 25 | $191.1M | $22.7M | ||
| Q3 25 | $192.5M | $34.0M | ||
| Q2 25 | $193.9M | $45.3M | ||
| Q1 25 | $195.0M | $56.7M | ||
| Q4 24 | $230.5M | $68.0M | ||
| Q3 24 | — | $79.3M | ||
| Q2 24 | — | $90.7M | ||
| Q1 24 | — | $102.0M |
股东权益ASPSPBYI
| Q4 25 | $-110.2M | $130.3M | ||
| Q3 25 | $-104.2M | $115.3M | ||
| Q2 25 | $-102.7M | $104.7M | ||
| Q1 25 | $-119.8M | $97.1M | ||
| Q4 24 | $-157.4M | $92.1M | ||
| Q3 24 | $-149.4M | $71.1M | ||
| Q2 24 | $-140.8M | $48.5M | ||
| Q1 24 | $-133.3M | $51.0M |
总资产ASPSPBYI
| Q4 25 | $139.8M | $216.3M | ||
| Q3 25 | $139.9M | $202.9M | ||
| Q2 25 | $142.9M | $194.9M | ||
| Q1 25 | $145.7M | $196.2M | ||
| Q4 24 | $143.6M | $213.3M | ||
| Q3 24 | $144.5M | $220.7M | ||
| Q2 24 | $146.6M | $205.0M | ||
| Q1 24 | $148.9M | $214.1M |
负债/权益比ASPSPBYI
| Q4 25 | — | 0.17× | ||
| Q3 25 | — | 0.30× | ||
| Q2 25 | — | 0.43× | ||
| Q1 25 | — | 0.58× | ||
| Q4 24 | — | 0.74× | ||
| Q3 24 | — | 1.12× | ||
| Q2 24 | — | 1.87× | ||
| Q1 24 | — | 2.00× |
现金流与资本效率
扣除再投资后实际产生的现金。现金流比净利润更难造假
| 指标 | | |
|---|---|---|
| 经营现金流最新季度 | $-505.0K | $14.4M |
| 自由现金流经营现金流 - 资本支出 | $-525.0K | $14.4M |
| 自由现金流率自由现金流/营收 | -1.2% | 19.1% |
| 资本支出强度资本支出/营收 | 0.0% | 0.0% |
| 现金转化率经营现金流/净利润 | — | — |
| 过去12个月自由现金流最近4个季度 | $-5.1M | $41.7M |
8季度趋势，按日历期对齐
经营现金流ASPSPBYI
| Q4 25 | $-505.0K | $14.4M | ||
| Q3 25 | $718.0K | $9.7M | ||
| Q2 25 | $-306.0K | $14.1M | ||
| Q1 25 | $-5.0M | $3.6M | ||
| Q4 24 | $-1.4M | $15.6M | ||
| Q3 24 | $-1.6M | $11.0M | ||
| Q2 24 | $180.0K | $1.0M | ||
| Q1 24 | $-2.2M | $11.2M |
自由现金流ASPSPBYI
| Q4 25 | $-525.0K | $14.4M | ||
| Q3 25 | $697.0K | $9.7M | ||
| Q2 25 | $-309.0K | $14.1M | ||
| Q1 25 | $-5.0M | $3.6M | ||
| Q4 24 | $-1.4M | $15.6M | ||
| Q3 24 | — | $11.0M | ||
| Q2 24 | — | $1.0M | ||
| Q1 24 | — | — |
自由现金流率ASPSPBYI
| Q4 25 | -1.2% | 19.1% | ||
| Q3 25 | 1.7% | 17.7% | ||
| Q2 25 | -0.7% | 26.8% | ||
| Q1 25 | -11.5% | 7.7% | ||
| Q4 24 | -3.4% | 26.4% | ||
| Q3 24 | — | 13.7% | ||
| Q2 24 | — | 2.1% | ||
| Q1 24 | — | — |
资本支出强度ASPSPBYI
| Q4 25 | 0.0% | 0.0% | ||
| Q3 25 | 0.1% | 0.0% | ||
| Q2 25 | 0.0% | 0.0% | ||
| Q1 25 | 0.1% | 0.1% | ||
| Q4 24 | 0.0% | 0.0% | ||
| Q3 24 | 0.0% | 0.0% | ||
| Q2 24 | 0.0% | 0.0% | ||
| Q1 24 | 0.0% | 0.0% |
现金转化率ASPSPBYI
| Q4 25 | — | — | ||
| Q3 25 | — | 1.10× | ||
| Q2 25 | -0.02× | 2.41× | ||
| Q1 25 | — | 1.21× | ||
| Q4 24 | — | — | ||
| Q3 24 | — | 0.54× | ||
| Q2 24 | — | — | ||
| Q1 24 | — | — |
财务流量对比
营收 → 毛利润 → 营业利润 → 净利润流向图
业务分部营收拆解
ASPS
| Services | $39.9M | 94% |
| Revenue Relatedto Technology Platformsand Professional Services | $2.4M | 6% |
PBYI
暂无分部数据
